Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST PROSTATE CANCER CONTENT
Evolving Standard of Care for mHSPC Prompts Interest in Deescalation
CBR Polling Shows Rapid Uptake of Darolutamide in mHSPC
Disease Factors Can Support Intensification or Deescalation in HSPC
Rates of Drug Interactions Differentiate ARPIs for Treating mHSPC
Considering the Evolution of ARPI Combination Therapy in mHSPC
Navigating ARANOTE Trial Findings and Insurance for Prostate Cancer
Applying Recent Trial Data to mHSPC Clinical Decision-Making
Analyzing Benefits and Safety of Darolutamide in mHSPC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement
